On social media, most of the microdosing chatter is about small amounts of weight loss, perceived (but not proven!) longevity benefits, and treating many forms of inflammation
Meet with your clinician: Have an in-depth discussion about your goals and create your personalized treatment plan
For many patients, yesthough results may vary depending on a patients personal lifestyle habits, as best outcomes are often paired with diet and exercise
When a patient self-administers research-grade BPC-157 and reports inconsistent results, the source variability is a plausible explanation that is rarely considered
Hi vng nhng ni dung ny c ch v gip bn dng whey hiu qu hn
Common signs of NAION include: Sudden, unilateral painless loss of vision Visual field defect (usually altitudinal) Blurred vision Dyschromatopsia (new onset impairment or loss of color vision) Relative afferent pupillary defect Optic disc swelling with or without hemorrhages A patient starting a GLP-1RAespecially if they have diabetes or age-related macular degeneration should have an in-person, comprehensive, dilated eye examination either within the 12 months prior to starting therapy or a baseline examination within one month of initiating therapy